Work

MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential Therapies for KRAS Mutated Colorectal Cancer That Is Resistant to EGFR Monoclonal Antibody Therapy

Year: 2010

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-10-3058

Authors: Juyong Yoon, Kyoung-Hwa Koo, Kang-Yell Choi

Institution: Yonsei University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Merck, Yonsei University College of Medicine

OpenAlex ID: W2091935713

FWCI: 4.748

Cites: 49

Cited by: 92

Related to: 10